CVS Health Corp (CVS · NYSE)

CVS · MARKET VIEW

Market view · as of Sep 14, 2026

Revenue (TTM)
$412.64B
+7.1% YoY
Gross margin
13.6%
EPS (latest q)
$2.58
vs $1.87 est · beat
52-wk position
62.7%
-13.9% vs 52w high · -0.3% 1mo

Price (last ~year)

CVS Health Corp reported $106.10 billion in revenue and $3.00 billion in net income for the quarter ending June 30, 2026, marking four consecutive quarterly earnings beats. The company holds a market capitalization of $121.07 billion against $76.31 billion in total debt, resulting in a 4.6x debt-to-EBITDA ratio. Shares recently traded at $94.66, reflecting a 5.4% decline over the last three months and a 52-week position of 62.7%.

Valuation

Market cap
$121.07B
P/E
24.98
PEG
0.222
P/B
1.519
P/S
0.293
EV/EBITDA
13.68
Beta
0.58
Analyst target
$116.04

Quality & returns

Gross margin
13.6%
Operating margin
3.9%
Profit margin
1.2%
ROE
6.2%
ROA
3.0%

Price movement

Last
$94.66
1-month
-0.3%
3-month
-5.4%
RSI (14)
56
vs SMA200
+10.0%
52-wk position
62.7% -13.9% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$106.10B$4.70B$3.00B$5.86B
2026-03-31$100.43B$4.68B$2.94B$5.83B
2025-12-31$105.69B$2.11B$2.94B$3.29B
2025-09-30$102.87B$-3.21B$-3.98B$-1.56B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots